Lucas Kempf, MD: FDA and Rare Disease Therapies
October 23, 2019
Lucas Kempf, MD, associate director of the FDA's Rare Diseases Program, discusses the impact of recent policy changes that center around increasing access to and creating new therapies for rare disease.